Michele L. Ries
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michele L. Ries has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Sterling C. Johnson
Wisconsin Alzheimer’s Disease Research Center, School of Medicine and Public Health, University of Wisconsin, Madison, USA
5 shared publications - Barbara B. Bendlin
Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
2 shared publications - Donald George McLaren
Vigil Neuroscience, Inc., Watertown, MA, USA
2 shared publications Howard A. Rowley
University of Wisconsin—Madison, USA 53705
2 shared publicationsMark A. Sager
University of Wisconsin—Madison, USA 53705
2 shared publicationsSanjay Asthana
Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison Wisconsin 53705
2 shared publications
Latest Publications
- Top Cited Papers
- 1 July 2012
- Published by Elsevier in NeuroImage
- Vol. 61 (4) , 1277-1286
A generalized form of context-dependent psychophysiological interactions (gPPI): A comparison to standard approaches
- 1 July 2012
- Published by Elsevier in NeuroImage
- Vol. 61 (4) , 1277-1286
Top Cited PapersA generalized form of context-dependent psychophysiological interactions (gPPI): A comparison to standard approaches
- 1 April 2012
- Published by Elsevier in Neuropsychologia
- Vol. 50 (5) , 603-611
Medial prefrontal functional connectivity—Relation to memory self-appraisal accuracy in older adults with and without memory disorders
- 1 April 2012
- Published by Elsevier in Neuropsychologia
- Vol. 50 (5) , 603-611
Medial prefrontal functional connectivity—Relation to memory self-appraisal accuracy in older adults with and without memory disorders
- Open Access
- 15 April 2009
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 3 (3) , 233-239
Posterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms
Depressive symptoms occurring late in life are an important risk factor for Alzheimer’s disease (AD). The latest research finds that onset of depressive symptoms in late life may herald the development of AD, not only for amnestic Mild Cognitive Impairment (aMCI) patients, but also for cognitively-normal older adults. Neuroimaging of brain structure, blood flow, and glucose metabolism indicates that depressive symptoms in late life are accompanied by structural and functional changes in limbic brain regions vulnerable to AD. The present cross-sectional study was guided by the hypothesis that compared to their non-depressed counterparts, older adults with mild to moderate depressive symptoms have less volume in limbic structures vulnerable to changes in AD—specifically, cortical midline structures such as anterior cingulate and posterior cingulate cortex as well as mesial temporal regions such as bilateral hippocampi and amygdalae. Consistent with our hypothesis, results of a voxel-based morphometry analysis revealed smaller retrosplenial, posterior cingulate, and precuneus gray matter volumes in depressed individuals relative to healthy controls. Right lateral parietal cortex—another region vulnerable to change in AD—was also smaller in the group with depressive symptoms. Contrary to our hypothesis, no volumetric differences were found in the anterior cingulate cortex or mesial temporal lobe. Results of this study show a relationship between geriatric depressive symptoms and brain volume in regions vulnerable to AD. Follow-up of participants over time will tell if brain changes detected here predict development of AD.
- 15 April 2009
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 3 (3) , 233-239
Open AccessPosterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms
Depressive symptoms occurring late in life are an important risk factor for Alzheimer’s disease (AD). The latest research finds that onset of depressive symptoms in late life may herald the development of AD, not only for amnestic Mild Cognitive Impairment (aMCI) patients, but also for cognitively-normal older adults. Neuroimaging of brain structure, blood flow, and glucose metabolism indicates that depressive symptoms in late life are accompanied by structural and functional changes in limbic brain regions vulnerable to AD. The present cross-sectional study was guided by the hypothesis that compared to their non-depressed counterparts, older adults with mild to moderate depressive symptoms have less volume in limbic structures vulnerable to changes in AD—specifically, cortical midline structures such as anterior cingulate and posterior cingulate cortex as well as mesial temporal regions such as bilateral hippocampi and amygdalae. Consistent with our hypothesis, results of a voxel-based morphometry analysis revealed smaller retrosplenial, posterior cingulate, and precuneus gray matter volumes in depressed individuals relative to healthy controls. Right lateral parietal cortex—another region vulnerable to change in AD—was also smaller in the group with depressive symptoms. Contrary to our hypothesis, no volumetric differences were found in the anterior cingulate cortex or mesial temporal lobe. Results of this study show a relationship between geriatric depressive symptoms and brain volume in regions vulnerable to AD. Follow-up of participants over time will tell if brain changes detected here predict development of AD.
- 11 April 2008
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 56 (5) , 920-934
Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review
Given the predicted increase in prevalence of Alzheimer's disease (AD) in the coming decades, early detection and intervention in persons with the predementia condition known as mild cognitive impairment (MCI) is of paramount importance. Recent years have seen remarkable advances in the application of neuroimaging and other biomarkers to the study of MCI. This article reviews the most recent developments in the use of magnetic resonance imaging (MRI) to characterize brain changes and to prognosticate clinical outcomes of patients with MCI. The review begins with description of methods and findings in structural MRI research, delineating findings regarding both gross atrophy and microstructural brain changes in MCI. Second, we describe the most recent findings regarding brain function in MCI, enumerating findings from functional MRI and brain perfusion studies. Third, we will make recommendations regarding the current clinical use of MRI in identification of MCI. As a conclusion, we will look to the future of neuroimaging as a tool in early AD detection.
- 11 April 2008
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 56 (5) , 920-934
Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review
Given the predicted increase in prevalence of Alzheimer's disease (AD) in the coming decades, early detection and intervention in persons with the predementia condition known as mild cognitive impairment (MCI) is of paramount importance. Recent years have seen remarkable advances in the application of neuroimaging and other biomarkers to the study of MCI. This article reviews the most recent developments in the use of magnetic resonance imaging (MRI) to characterize brain changes and to prognosticate clinical outcomes of patients with MCI. The review begins with description of methods and findings in structural MRI research, delineating findings regarding both gross atrophy and microstructural brain changes in MCI. Second, we describe the most recent findings regarding brain function in MCI, enumerating findings from functional MRI and brain perfusion studies. Third, we will make recommendations regarding the current clinical use of MRI in identification of MCI. As a conclusion, we will look to the future of neuroimaging as a tool in early AD detection.
- Open Access
- 13 January 2006
- Published by Springer Nature in BMC Medicine
- Vol. 4 (1) , 1
Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's Disease: a cross-sectional study
Background: The presence of the apolipoprotein E (APOE) ε4 allele is a major risk factor for the development of Alzheimer's disease (AD), and has been associated with metabolic brain changes several years before the onset of typical AD symptoms. Functional MRI (fMRI) is a brain imaging technique that has been used to demonstrate hippocampal activation during measurement of episodic encoding, but the effect of the ε4 allele on hippocampal activation has not been firmly established. Methods: The present study examined the effects of APOE genotype on brain activation patterns in the medial temporal lobe (MTL) during an episodic encoding task using a well-characterized novel item versus familiar item contrast in cognitively normal, middle-aged (mean = 54 years) individuals who had at least one parent with AD. Results: We found that ε3/4 heterozygotes displayed reduced activation in the hippocampus and MTL compared to ε3/3 homozygotes. There were no significant differences between the groups in age, education or neuropsychological functioning, suggesting that the altered brain activation seen in ε3/4 heterozygotes was not associated with impaired cognitive function. We also found that participants' ability to encode information on a neuropsychological measure of learning was associated with greater activation in the anterior MTL in the ε3/3 homozygotes, but not in the ε3/4 heterozygotes. Conclusion: Together with previous studies reporting reduced glucose metabolism and AD-related neuropathology, this study provides convergent validity for the idea that the MTL exhibits functional decline associated with the APOE ε4 allele. Importantly, these changes were detected in the absence of meaningful neuropsychological differences between the groups. A focus of ongoing work in this laboratory is to determine if these findings are predictive of subsequent cognitive decline.
- 13 January 2006
- Published by Springer Nature in BMC Medicine
- Vol. 4 (1) , 1
Open AccessReduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's Disease: a cross-sectional study
Background: The presence of the apolipoprotein E (APOE) ε4 allele is a major risk factor for the development of Alzheimer's disease (AD), and has been associated with metabolic brain changes several years before the onset of typical AD symptoms. Functional MRI (fMRI) is a brain imaging technique that has been used to demonstrate hippocampal activation during measurement of episodic encoding, but the effect of the ε4 allele on hippocampal activation has not been firmly established. Methods: The present study examined the effects of APOE genotype on brain activation patterns in the medial temporal lobe (MTL) during an episodic encoding task using a well-characterized novel item versus familiar item contrast in cognitively normal, middle-aged (mean = 54 years) individuals who had at least one parent with AD. Results: We found that ε3/4 heterozygotes displayed reduced activation in the hippocampus and MTL compared to ε3/3 homozygotes. There were no significant differences between the groups in age, education or neuropsychological functioning, suggesting that the altered brain activation seen in ε3/4 heterozygotes was not associated with impaired cognitive function. We also found that participants' ability to encode information on a neuropsychological measure of learning was associated with greater activation in the anterior MTL in the ε3/3 homozygotes, but not in the ε3/4 heterozygotes. Conclusion: Together with previous studies reporting reduced glucose metabolism and AD-related neuropathology, this study provides convergent validity for the idea that the MTL exhibits functional decline associated with the APOE ε4 allele. Importantly, these changes were detected in the absence of meaningful neuropsychological differences between the groups. A focus of ongoing work in this laboratory is to determine if these findings are predictive of subsequent cognitive decline.
- 1 January 2006
- Published by Elsevier in Neuropsychologia
- Vol. 44 (12) , 2233-2240
Heightened false memory: A long-term sequela of severe closed head injury
- 1 January 2006
- Published by Elsevier in Neuropsychologia
- Vol. 44 (12) , 2233-2240
Heightened false memory: A long-term sequela of severe closed head injury
- 1 January 2005
- Published by American Psychological Association (APA) in Neuropsychology
- Vol. 19 (4) , 476-483
Selective Attention Deficits Following Severe Closed Head Injury: The Role of Inhibitory Processes.
Heightened distractibility following severe closed head injury (sCHI) may result from a deficit in selective attention. The integrity of inhibitory processes involved in selective attention was assessed through use of a negative priming paradigm, allowing dissociation of inhibitory and episodic retrieval processes. In this task, inhibitory processes are elicited under intact stimulus conditions, whereas episodic retrieval is elicited when target stimuli are degraded. Despite inconsistent evidence of inhibitory deficits following sCHI in the literature, long-term survivors of sCHI showed no negative priming under intact stimulus conditions, providing evidence of compromised inhibitory processing. The sCHI participants' demonstration of negative priming when target stimuli were degraded provides evidence that automatic retrieval processes are intact following sCHI, results that are consistent with prior findings.
- 1 January 2005
- Published by American Psychological Association (APA) in Neuropsychology
- Vol. 19 (4) , 476-483
Selective Attention Deficits Following Severe Closed Head Injury: The Role of Inhibitory Processes.
Heightened distractibility following severe closed head injury (sCHI) may result from a deficit in selective attention. The integrity of inhibitory processes involved in selective attention was assessed through use of a negative priming paradigm, allowing dissociation of inhibitory and episodic retrieval processes. In this task, inhibitory processes are elicited under intact stimulus conditions, whereas episodic retrieval is elicited when target stimuli are degraded. Despite inconsistent evidence of inhibitory deficits following sCHI in the literature, long-term survivors of sCHI showed no negative priming under intact stimulus conditions, providing evidence of compromised inhibitory processing. The sCHI participants' demonstration of negative priming when target stimuli were degraded provides evidence that automatic retrieval processes are intact following sCHI, results that are consistent with prior findings.